Vimarsana
Biggest News Aggregation in the World

Page 8 - Sci Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sci Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sci Communications Today - Breaking & Trending Today

9 Meters Biopharma Provides Business Update and Reports Financial Results for Fourth Quarter and Full Year 2021 - Vimarsana News

9 Meters Biopharma Provides Business Update and Reports Financial Results for Fourth Quarter and Full Year 2021

Published: March 23, 2022

RALEIGH, NC / ACCESSWIRE / March 23, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today provided

Source: finanznachrichten.de
Related Topics:
United StatesAl MedwarJohn TemperatoCarol Rees ParrishGustave RoussyBethany SensenigSarah LiuVeronica EamesLangone HealthEuropean Biomedical Research Institute Of SalernoBiogen IncMeters Biopharma IncBiodelivery SciencesTrademark OfficeCompany Annual Report On FormLifesci CommunicationsInvestor Relations Corporate CommunicationsClinical DevelopmentChief Financial OfficerChief Commercial OfficerInvestor RelationsSupport SpecialistCeliac DiseaseEuropean Biomedical Research InstituteCritical Care Explorations
9 Meters Biopharma to Present at the Oppenheimer 32nd Annual Healthcare Conference - Vimarsana News

9 Meters Biopharma to Present at the Oppenheimer 32nd Annual Healthcare Conference

Published: March 9, 2022

09.03.2022 - RALEIGH, NC / ACCESSWIRE / March 9, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced today that John Temperato, President & Chief ...

Source: wallstreet-online.de
Related Topics:
Al MedwarVeronica EamesCompany Annual Report On FormLifesci CommunicationsMeters Biopharma IncInvestor Relations Corporate CommunicationsPresentation DateAnnual ReportInvestor RelationsSci Communications
Mundipharma and Cidara Therapeutics, Inc.: Rezafungin Awarded Promising Innovation Medicine (PIM) Designation by the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Invasive Candidiasis - Vimarsana News

Mundipharma and Cidara Therapeutics, Inc.: Rezafungin Awarded Promising Innovation Medicine (PIM) Designation by the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Invasive Candidiasis

Published: March 3, 2022

For Trade and Medical Media Only Rezafungin is a next-generation once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections, such as invasive candidiasis

Source: finanznachrichten.de
Related Topics:
United StatesSan DiegoUnited KingdomTaylor SandisonPatrick BurseyBrian SheehanJan Milton EdwardsAsia PacificBrian RitchieCommunity RegisterCidara Therapeutics IncEuropean CommissionDrug AdministrationExchange CommissionUs Food Drug AdministrationLifesci CommunicationsEuropean Medicines AgencySecurities ExchangeHealthcare Products Regulatory AgencyFor TradeMedical Media OnlyInnovation MedicineEarly AccessMedicines SchemeCidara Therapeutics
9 Meters Biopharma Announces a Collaboration with NYU Langone Health Investigating NM-102 as a Potential Treatment for an Autoimmune Disorder - Vimarsana News

9 Meters Biopharma Announces a Collaboration with NYU Langone Health Investigating NM-102 as a Potential Treatment for an Autoimmune Disorder

Published: March 2, 2022

RALEIGH, NC / ACCESSWIRE / March 2, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced

Source: finanznachrichten.de
Related Topics:
Al MedwarPatrickh GriffinGregg SilvermanVeronica EamesLangone HealthLangone Judith Stewart Colton CenterMeters Biopharma IncCompany Annual Report On FormColton CenterLifesci CommunicationsInvestor Relations Corporate CommunicationsChief Medical OfficerStewart Colton CenterAnnual ReportInvestor RelationsSci Communications
9 Meters Biopharma : Provides Clinical Update on Late-Stage Pipeline Products Vurolenatide for Short Bowel Syndrome and Larazotide for Celiac Disease - Form 8-K - Vimarsana News

9 Meters Biopharma : Provides Clinical Update on Late-Stage Pipeline Products Vurolenatide for Short Bowel Syndrome and Larazotide for Celiac Disease - Form 8-K

Published: February 28, 2022

9 Meters Biopharma Provides Clinical Update on Late-Stage Pipeline Products Vurolenatide for Short Bowel Syndrome and Larazotide for Celiac Disease RALEIGH, NC... | February 28, 2022

Source: marketscreener.com
Related Topics:
Al MedwarJohn TemperatoPatrickh GriffinVeronica EamesCompany Annual Report On FormCompany PhaseLifesci CommunicationsMeters Biopharma IncInvestor Relations Corporate CommunicationsBiopharma Provides Clinical UpdateLate Stage Pipeline Products VurolenatideShort Bowel SyndromeCeliac DiseaseChief Medical OfficerAbdominal DomainChief Executive OfficerAnnual ReportInvestor RelationsCorporate CommunicationsSci Communications9 Meters BiopharmaNc Stock ExchangePress ReleaseEliac Nmtr Us6544051096